Metraipolis › archive › dc_d45308326ab1

Dosimetric benefits of half-field arc in prostate cancer treatment — Europe PMC PMID:41212382

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41212382
DOI
10.1007/s13246-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-08T17:02:16.255Z
SHA-256 of the archived text
e4e68aa4b8bacc8431abe167bac9bfc6a3807235cffb5dd5c28aebcfa618d211
Stable URL of this page
https://metraipolis.com/documento/dc_d45308326ab1

How to cite

Dosimetric benefits of half-field arc in prostate cancer treatment — Europe PMC PMID:41212382 — Europe PMC (en), https://europepmc.org/article/MED/41212382 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d45308326ab1 (Metraipolis archive dc_d45308326ab1, sha256 e4e68aa4b8bacc8431abe167bac9bfc6a3807235cffb5dd5c28aebcfa618d211)
BibTeX
@misc{dcd45308326ab1,
  title = {Dosimetric benefits of half-field arc in prostate cancer treatment — Europe PMC PMID:41212382},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41212382},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d45308326ab1; sha256 e4e68aa4b8bacc8431abe167bac9bfc6a3807235cffb5dd5c28aebcfa618d211},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41212382. Agents can read the archived copy with the MCP tool read_document.